Now showing items 1-3 of 3

    • Fabry nephropathy: an evidence-based narrative review 

      Pino, María Dolores del; Andrés, Amado; Ávila Bernabéu, Ana; Juan-Rivera, Joaquín de; Fernández i Giráldez, Elvira; García Díaz, Juan de Dios; Hernández, Domingo; Luño, José; Martínez Fernández, Isabel; Paniagua, José; Torra, Roser; Torras Ambros, Joan; Vidau, Pedro; Torregrosa, José Vicente (Karger Publishers Open Access, 2018)
      Fabry disease (FD) is a rare, X-linked disorder caused by mutations in the GLA gene encoding the enzyme α-galactosidase A. Complete or partial deficiency in this enzyme leads to intracellular accumulation of globotriaosylceramide ...
    • Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study 

      Abajo, María; Betriu i Bars, M. Àngels; Arroyo, David; Gracia, Marta; Pino, María Dolores del; Martínez, Isabel; Valdivielso Revilla, José Manuel; Fernández i Giráldez, Elvira (Oxford University Press, 2017-08-27)
      BACK GROUND: The leading cause of premature death in chronic kidney disease (CKD) is cardiovascular disease (CVD), but risk assessment in renal patients is challenging. The aim of the study was to analyse the factors that ...
    • The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem 

      Ortiz, Alberto; Sanchez-Niño, Maria-Dolores; Crespo-Barrio, Marta; De-Sequera-Ortiz, Patricia; Fernández i Giráldez, Elvira; García-Maset, Rafael; Macía-Heras, Manuel; Pérez Fontán, Miguel; Rodríguez, Mariano; Salgueira-Lazo, Mercedes; Sánchez Álvarez, Emilio; Santamaría-Olmo, Rafael; Simal-Blanco, Fernando; Pino, María Dolores del (Elsevier, 2019)
      The Global Burden of Disease (GBD) study measures the health of populations worldwide and by country on an annual basis and aims at helping guide public policy on health issues. The GBD estimates for Spain in 2016 and ...